Engineered killer T cells could provide longlasting immunity against cancer

Engineered killer T cells could provide long-lasting immunity against cancer

In experiments with mice, researchers have shown they can harness the power of iNKT cells to attack tumor cells and treat cancer. The new method suppressed the growth of multiple types of human tumors that had been transplanted into the animals.

More From BioPortfolio on "Engineered killer T cells could provide long-lasting immunity against cancer"